In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
  • Select events

    Select Select events(s)

  • Year

    Select Year(s)

  • Resource type

    Select Resource type(s)

  • Topic

    Select Topic(s)

Filters (0)
  • Select events
  • sub-topic
  • Year
  • Resource type
  • Topic
  • Select events
  • sub-topic
  • Year
  • Resource type
  • Topic

Sponsored content

Presentations below are part of sessions sponsored by Novartis Pharma AG

56 results for your search

How to achieve the optimisation we aim for.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Novartis

Optimising treatment for patients in the vulnerable phase.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : J Butler (Atlanta,US)
  • Sponsored by Novartis

Panel discussion - Making critical choices for patients at the right time.

Event : Heart Failure 2019

  • Session : Making critical choices for patients at the right time – Join the discussion
  • Speaker : F Ruschitzka (Zurich,CH), JJV McMurray (Glasgow,GB), M Senni (Bergamo,IT), J Butler (Atlanta,US)
  • Sponsored by Novartis

Panel discussion - Treatment choices to optimise benefits for heart failure patients.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : F Ruschitzka (Zurich,CH), JJV McMurray (Glasgow,GB), M Senni (Bergamo,IT), J Butler (Atlanta,US)
  • Sponsored by Novartis

Personalising care for heart failure patients.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : JJV McMurray (Glasgow,GB)
  • Sponsored by Novartis

Summary and conclusion - Treatment choices to optimise benefits for heart failure patients.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : JJV McMurray (Glasgow,GB)
  • Sponsored by Novartis

Welcome and introduction - Treatment choices to optimise benefits for heart failure patients.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Novartis

Welcome video.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Sponsored by Novartis

Audience Q&A and panel discussion.

Event : ESC Congress 2018

  • Session : Emerging evidence-based approaches to reduce residual atherosclerotic risk
  • Speaker : W Koenig (Munich,DE), P Libby (Boston,US), PM Ridker (Boston,US), JH Cornel (Alkmaar,NL)
  • Sponsored by Novartis Pharma AG

Case 2: My HF patient post-hospitalization is easy to manage!

Event : Heart Failure 2018

  • Session : Heart failure case debates with the experts
  • Speaker : CS Lam (Singapore,SG), J Cleland (Glasgow,GB)
  • Organised by Medscape Education, supported with an educational grant by Novartis

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are